hackettg

Class 3 Medicines Recall: Atomoxetine 10mg, 18mg, 25mg, 40mg Capsules (Neuraxpharm UK Ltd) Drug alert number: EL (24)A/19 Date issued: 5 June 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 3 medicines recall for: Atomoxetine 10mg, 18mg, 25mg, 40mg Capsules (Neuraxpharm UK Ltd) Company name: Neuraxpharm UK Ltd Product name: Atomoxetine [...]

The post MHRA Class 3 Medicines Recall: Atomoxetine 10mg, 18mg, 25mg, 40mg Capsules (Neuraxpharm UK Ltd) appeared first on Community Pharmacy England.

Following representations from Community Pharmacy England, the Department of Health of Social Care (DHSC) has re-determined the special container status of Drospirenone (Slynd®) 4mg tablets. From 1 June 2024, Drospirenone (Slynd®) 4mg tablets were re-classified as a special container at sub-pack level (sub-pack of 28) as they meet the relevant criteria as set out in Part II [...]

The post Drospirenone (Slynd®) 4mg tablets re-classified as a special container appeared first on Community Pharmacy England.

A recent report published by Healthwatch England highlights that the cost of living pressures are affecting people’s ability to afford prescription and over-the-counter medicines.  Freedom of Information data from 2021, found that over a million people could have saved money through NHS prescription prepayment certificates (PPCs). Therefore, Healthwatch England is calling for improvements to NHS [...]

The post Promoting NHS prescription prepayment certificates appeared first on Community Pharmacy England.

The Drug Tariff Preface published monthly, lists additions, deletions and other changes to products listed in the Drug Tariff. Below is a summary of the changes coming into effect from 1 June 2024. Key g Special container – This product is a special container and should be dispensed in its complete original pack size. n Item requiring reconstitution [...]

The post Drug Tariff Watch – June 2024 appeared first on Community Pharmacy England.

The MHRA has re-issued this notification as Class 3 recall based on further assessment. Please note the new actions for healthcare professionals listed within the notification. Doncaster Pharma Limited have identified an error relating to the Braille printed on the cartons on various parallel imported packs which have been repackaged by BModesto B.V. Class 3 [...]

The post MHRA Class 3 Medicines Recall: Keppra 500mg film-coated tablets (Doncaster Pharma Limited) appeared first on Community Pharmacy England.